These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 16552233)

  • 1. Disease mechanism and biomarkers of oral squamous cell carcinoma.
    Brinkman BM; Wong DT
    Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers in oral epithelial dysplasia: review.
    Pitiyage G; Tilakaratne WM; Tavassoli M; Warnakulasuriya S
    J Oral Pathol Med; 2009 Nov; 38(10):737-52. PubMed ID: 19903246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hamster model of sequential oral oncogenesis.
    Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
    Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma.
    Banerjee AG; Bhattacharyya I; Lydiatt WM; Vishwanatha JK
    Cancer Res; 2003 Nov; 63(22):7769-76. PubMed ID: 14633702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for oral premalignancy and cancer: what platform and which biomarkers?
    Lingen MW
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1056-9. PubMed ID: 20798207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Precancerous lesions of the buccal mucosa].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic progression model of oral cancer: current evidence and clinical implications.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis.
    Sawhney M; Rohatgi N; Kaur J; Gupta SD; Deo SV; Shukla NK; Ralhan R
    Oral Oncol; 2007 May; 43(5):515-22. PubMed ID: 16996781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
    Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
    Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular aspects of oral cancer.
    Nagler RM
    Anticancer Res; 2002; 22(5):2977-80. PubMed ID: 12530028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of molecular markers to predict malignant potential of oral precancer.
    Warnakulasuriya S
    J Pathol; 2000 Mar; 190(4):407-9. PubMed ID: 10699986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of oral cavity squamous cell carcinoma.
    Kupferman ME; Myers JN
    Otolaryngol Clin North Am; 2006 Apr; 39(2):229-47. PubMed ID: 16580909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Opportunities and chances for tissue chip microarrays in head and neck surgery. A novel technique for the rapid evaluation of potentially novel biomarkers].
    Hofele C; Joos S; Flechtenmacher C; Bosch FX; Lichter P; Mühling J; Freier K
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):394-401. PubMed ID: 12447651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral squamous cell carcinoma: new insights.
    Jordan RC; Daley T
    J Can Dent Assoc; 1997; 63(7):517-8, 521-5. PubMed ID: 9264211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in oral squamous cell carcinoma. A review of the literature.
    Tralongo V; Rodolico V; Luciani A; Marra G; Daniele E
    Anticancer Res; 1999; 19(4C):3503-10. PubMed ID: 10629643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a gene signature for rapid screening of oral squamous cell carcinoma.
    Ziober AF; Patel KR; Alawi F; Gimotty P; Weber RS; Feldman MM; Chalian AA; Weinstein GS; Hunt J; Ziober BL
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5960-71. PubMed ID: 17062667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic role of clinical, morphological and molecular markers in oral squamous cell tumors.
    Németh Z; Velich N; Bogdan S; Ujpál M; Szabó G; Suba ZS
    Neoplasma; 2005; 52(2):95-102. PubMed ID: 15800706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.